Search: id:"swepub:oai:DiVA.org:uu-160736" >
Synthesis and struc...
-
Makatini, Maya M.
(author)
Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors : A hybrid 2D NMR and docking/QM/MM/MD approach
- Article/chapterEnglish2011
Publisher, publication year, extent ...
-
Elsevier BV,2011
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-160736
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-160736URI
-
https://doi.org/10.1016/j.ejmech.2011.05.071DOI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-80017URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Pentacycloundecane (PCU) lactam-peptide based HIV protease inhibitors were synthesized and nanomolar activity against the resistance-prone wild type C-South African HIV protease is reported. NMR investigations indicated that the activity is related to the chirality of the PCU moiety and its ability to induce conformations of the coupled peptide side chain. EASY-ROESY NMR experiments gave information about the 3D structure of the cage peptides and 3D solution structure could be linked to the experimental IC(50) activity profile of the considered inhibitors. QM/MM/MD simulations of the inhibitors in solution confirmed the NMR observed conformations. Docking experiments and QM/MM/MD simulations of the inhibitor-HIV PR complexes were also performed. These computational results complimented the experimental inhibition activities and enabled us to report a unique binding mode for PCU-based inhibitors at the active site of HIV-protease enzyme. A conserved hydrogen bonding pattern between the norstatine type functional group of the PCU hydroxylactam and active site residues, ASP25/ASP25', was observed in all active compounds. The biological significance and possible mode of inhibition by PCU-based HIV PR inhibitors discussed herein provide us with a deeper understanding of the mode of action of these novel inhibitors. The PCU-peptides are between 6000 and 8500 time less toxic to human MT-4 cells than Lopinavir. This potentially creates new application avenues for these putative inhibitors to be investigated against a vast number of other disease-related proteases.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Petzold, KatjaSchool of Chemistry, University of KwaZulu-Natal, Varsity Drive, Durban 4001, South Africa(Swepub:umu)kape0005
(author)
-
Sriharsha, Shimoga N.
(author)
-
Ndlovu, N.
(author)
-
Soliman, Mahmoud E. S.
(author)
-
Honarparvar, Bahareh
(author)
-
Parboosing, Raveen
(author)
-
Naidoo, Anneta
(author)
-
Arvidsson, Per I.Uppsala universitet,Avdelningen för organisk farmaceutisk kemi(Swepub:uu)pearv049
(author)
-
Sayed, Yasien
(author)
-
Govender, Patrick
(author)
-
Maguire, Glenn E. M.
(author)
-
Kruger, Hendrik G.
(author)
-
Govender, Thavendran
(author)
-
School of Chemistry, University of KwaZulu-Natal, Varsity Drive, Durban 4001, South AfricaAvdelningen för organisk farmaceutisk kemi
(creator_code:org_t)
Related titles
-
In:European Journal of Medicinal Chemistry: Elsevier BV46:9, s. 3976-39850223-52341768-3254
Internet link
Find in a library
To the university's database
- By the author/editor
-
Makatini, Maya M ...
-
Petzold, Katja
-
Sriharsha, Shimo ...
-
Ndlovu, N.
-
Soliman, Mahmoud ...
-
Honarparvar, Bah ...
-
show more...
-
Parboosing, Rave ...
-
Naidoo, Anneta
-
Arvidsson, Per I ...
-
Sayed, Yasien
-
Govender, Patric ...
-
Maguire, Glenn E ...
-
Kruger, Hendrik ...
-
Govender, Thaven ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Basic Medicine
-
and Medicinal Chemis ...
- Articles in the publication
-
European Journal ...
- By the university
-
Uppsala University
-
Umeå University